Skip to main content
. 2024 Mar 14;15:1355198. doi: 10.3389/fimmu.2024.1355198

Figure 4.

Figure 4

Survival between subgroups of concurrent immune checkpoint inhibitors cycles. (A) Progression-free survival. (B) Overall survival.